Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm’s canal endothelial cells
Schlemm's canal
Rho kinase inhibitor
DOI:
10.1038/srep19640
Publication Date:
2016-01-19T09:32:10Z
AUTHORS (7)
ABSTRACT
Abstract Ripasudil hydrochloride hydrate (K-115), a specific Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor, was the first ophthalmic solution developed for treatment of glaucoma and ocular hypertension in Japan. Topical administration K-115 decreased intraocular pressure (IOP) increased outflow facility rabbits. This study evaluated effect on monkey trabecular meshwork (TM) cells Schlemm’s canal endothelial (SCE) cells. induced retraction rounding cell bodies as well disruption actin bundles TM In SCE-cell monolayer permeability studies, significantly transendothelial electrical resistance (TEER) flux FITC-dextran. Further, disrupted cellular localization ZO-1 expression monolayers. These results indicate that decreases IOP by increasing association with modulation behavior SCE tight junction.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (130)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....